“Favorable Transactions” for Nesp in Return for Support in Clinical Trial: Independent Panel

There were “favorable transactions” of Kyowa Hakko Kirin’s renal anemia treatment Nesp (recombinant darbepoetin alfa) at a hospital in Sapporo in return for support it received for its Nesp clinical trial from the drug maker, an independent panel that investigated...read more